Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October... see more

Recent & Breaking News (TSXV:AVCR)

Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab(TM) Platform

GlobeNewswire April 21, 2026

HealthTab(TM) to Expand Across North East London

GlobeNewswire January 14, 2026

HealthTab(TM) to Power NHS Pilot

GlobeNewswire November 27, 2025

Avricore Health's HealthTab(TM) Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project

GlobeNewswire July 10, 2025

Avricore Grants Options

GlobeNewswire June 14, 2025

Avricore Appoints Rodger Seccombe as CEO

GlobeNewswire June 5, 2025

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report

GlobeNewswire June 2, 2025

AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track

GlobeNewswire May 1, 2025

HealthTab(TM) and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

GlobeNewswire January 29, 2025

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

GlobeNewswire November 29, 2024

Avricore Health Refocuses Strategy to Unlock Growth Potential

GlobeNewswire November 14, 2024

Avricore Health Recognized in Deloitte's 2024 Technology Fast 50(TM) Companies to Watch

GlobeNewswire November 6, 2024

Avricore Grants Options

GlobeNewswire August 30, 2024

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

GlobeNewswire August 29, 2024

AVRICORE HEALTH CORPORATE UPDATE - COMPANY ACHIEVES PROFITABILITY

GlobeNewswire June 3, 2024

Avricore Health Corporate Update and Audited Results for 2023

GlobeNewswire April 30, 2024

HealthTab(TM) Signs Agreement for More Rexall® Pharmacy Locations

GlobeNewswire April 4, 2024

Avricore Health Corporate Update - Company Demonstrates Strong Growth

GlobeNewswire November 30, 2023

HealthTab(TM) Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

GlobeNewswire September 15, 2023

Avricore Health Corporate Update - Mid-Year Review Demonstrates Company on Right Track

GlobeNewswire August 30, 2023

Podcasts